Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

Vive La France: Regulatory Approval Received

Jun 20, 2016Mark EdwardsNews

21 June 2016

ASX ANNOUNCEMENT

Vive La France: Regulatory Approval Received

Medical Developments International Limited (ASX: MVP) is delighted to announce it has received Marketing Authorisation for Penthrox in France for the emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain.

MVP CEO, Mr John Sharman, said: “This is an exciting achievement for MVP.  With French approval we can begin to sell product in France and Belgium.  Preparations for the launch of Penthrox in France and Belgium are well advanced.”

For details relating to the full ASX release please click on the following link French Regulatory Approval Received

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter